Stocktoria
Enliven Therapeutics, Inc. ELVN
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-03-12
Enliven Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| CITADEL ADVISORS LLC | 2,140,992 | $108.7M | 3.6% |
| BlackRock Finance, Inc. | 2,730,773 | $63.8M | 4.59% |
| MILLENNIUM MANAGEMENT LLC | 411,362 | $20.9M | 0.69% |
| D. E. Shaw & Co., Inc. | 305,703 | $15.5M | 0.51% |
| TWO SIGMA INVESTMENTS, LP | 22,758 | $1.2M | 0.04% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.